LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation

LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation

Alzheimer’s disease (AD) is the most common form of dementia in the elderly. It may be caused by oxidative stress, inflammation, and cerebrovascular dysfunctions in the brain. LongShengZhi Capsule (LSZ), a traditional Chinese medicine, has been approved by the China Food and Drug Administration for...

Full description

Bibliographic Details
Main Authors: Zequn Yin, Xuerui Wang, Shihong Zheng, Peichang Cao, Yuanli Chen, Maoyun Yu, Chenzhong Liao, Zhongyuan Zhang, Jihong Han, Yajun Duan, Xiaoxiao Yang, Shuang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
LongShengZhi capsule
Alzheimer’s disease
oxidative stress
amyloid-β
Tau
cognition
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.582455/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2020.582455/full

Similar Items